(19)
(11) EP 1 984 004 A2

(12)

(88) Date of publication A3:
10.01.2008

(43) Date of publication:
29.10.2008 Bulletin 2008/44

(21) Application number: 07718218.6

(22) Date of filing: 17.01.2007
(51) International Patent Classification (IPC): 
A61K 31/715(2006.01)
(86) International application number:
PCT/US2007/001427
(87) International publication number:
WO 2007/084661 (26.07.2007 Gazette 2007/30)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 17.01.2006 US 334763

(71) Applicants:
  • Sloan-Kettering Institute For Cancer Research
    New York, New York 10021 (US)
  • Biotec Pharmacon ASA
    9008 Tromsö (NO)

(72) Inventor:
  • ENGSTAD, Rolf Einar
    N-9018 Tromsø (NO)

(74) Representative: Gardner, Rebecca Katherine 
Frank B. Dehn & Co. St Bride's House 10 Salisbury Square
London EC4Y 8JD
London EC4Y 8JD (GB)

   


(54) THERAPY-ENHANCING GLUCAN